525 related articles for article (PubMed ID: 16518809)
21. Correlation of CpG island methylator phenotype with poor prognosis in hepatocellular carcinoma.
Cheng Y; Zhang C; Zhao J; Wang C; Xu Y; Han Z; Jiang G; Guo X; Li R; Bu X; Wu M; Wei L
Exp Mol Pathol; 2010 Feb; 88(1):112-7. PubMed ID: 19879258
[TBL] [Abstract][Full Text] [Related]
22. CpG island methylation in carcinoid and pancreatic endocrine tumors.
Chan AO; Kim SG; Bedeir A; Issa JP; Hamilton SR; Rashid A
Oncogene; 2003 Feb; 22(6):924-34. PubMed ID: 12584572
[TBL] [Abstract][Full Text] [Related]
23. Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes.
Matsusaka K; Kaneda A; Nagae G; Ushiku T; Kikuchi Y; Hino R; Uozaki H; Seto Y; Takada K; Aburatani H; Fukayama M
Cancer Res; 2011 Dec; 71(23):7187-97. PubMed ID: 21990320
[TBL] [Abstract][Full Text] [Related]
24. DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis.
Bernal C; Vargas M; Ossandón F; Santibáñez E; Urrutia J; Luengo V; Zavala LF; Backhouse C; Palma M; Argandoña J; Aguayo F; Corvalán A
Biol Res; 2008; 41(3):303-15. PubMed ID: 19399343
[TBL] [Abstract][Full Text] [Related]
25. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
[TBL] [Abstract][Full Text] [Related]
26. Integrated analysis of genetic and epigenetic alterations reveals CpG island methylator phenotype associated with distinct clinical characters of lung adenocarcinoma.
Shinjo K; Okamoto Y; An B; Yokoyama T; Takeuchi I; Fujii M; Osada H; Usami N; Hasegawa Y; Ito H; Hida T; Fujimoto N; Kishimoto T; Sekido Y; Kondo Y
Carcinogenesis; 2012 Jul; 33(7):1277-85. PubMed ID: 22532250
[TBL] [Abstract][Full Text] [Related]
27. Biological significance of promoter hypermethylation of tumor-related genes in patients with gastric carcinoma.
Ksiaa F; Ziadi S; Amara K; Korbi S; Trimeche M
Clin Chim Acta; 2009 Jun; 404(2):128-33. PubMed ID: 19336228
[TBL] [Abstract][Full Text] [Related]
28. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
Zhou YN; Xu CP; Han B; Ji R
Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
[TBL] [Abstract][Full Text] [Related]
29. [Relationship between CpG island methylator phenotype and genetic instability in sporadic colorectal cancer].
Cai GX; Xu Y; Cai SJ; Shi YQ; Lian P; Peng JJ; Guan ZQ; Du X
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Nov; 10(6):555-60. PubMed ID: 18000779
[TBL] [Abstract][Full Text] [Related]
30. CpG island methylator phenotype (CIMP) in cancer: causes and implications.
Teodoridis JM; Hardie C; Brown R
Cancer Lett; 2008 Sep; 268(2):177-86. PubMed ID: 18471961
[TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of primary gastric cancer, corresponding xenografts, and 2 novel gastric carcinoma cell lines reveals novel alterations in gastric carcinogenesis.
Milne AN; Sitarz R; Carvalho R; Polak MM; Ligtenberg M; Pauwels P; Offerhaus GJ; Weterman MA
Hum Pathol; 2007 Jun; 38(6):903-13. PubMed ID: 17376510
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of Epstein-Barr virus involvement in gastric carcinoma in Japan.
Koriyama C; Akiba S; Itoh T; Kijima Y; Sueyoshi K; Corvalan A; Herrera-Goepfer R; Eizuru Y
Int J Mol Med; 2002 Nov; 10(5):635-9. PubMed ID: 12373307
[TBL] [Abstract][Full Text] [Related]
33. CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas.
Abe M; Ohira M; Kaneda A; Yagi Y; Yamamoto S; Kitano Y; Takato T; Nakagawara A; Ushijima T
Cancer Res; 2005 Feb; 65(3):828-34. PubMed ID: 15705880
[TBL] [Abstract][Full Text] [Related]
34. CpG island methylator phenotype infers a poor disease-free survival in locally advanced rectal cancer.
Jo P; Jung K; Grade M; Conradi LC; Wolff HA; Kitz J; Becker H; Rüschoff J; Hartmann A; Beissbarth T; Müller-Dornieden A; Ghadimi M; Schneider-Stock R; Gaedcke J
Surgery; 2012 Apr; 151(4):564-70. PubMed ID: 22001634
[TBL] [Abstract][Full Text] [Related]
35. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
[TBL] [Abstract][Full Text] [Related]
36. Identification of genes targeted by CpG island methylator phenotype in neuroblastomas, and their possible integrative involvement in poor prognosis.
Abe M; Watanabe N; McDonell N; Takato T; Ohira M; Nakagawara A; Ushijima T
Oncology; 2008; 74(1-2):50-60. PubMed ID: 18544995
[TBL] [Abstract][Full Text] [Related]
37. Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas.
Wen XZ; Akiyama Y; Baylin SB; Yuasa Y
Oncogene; 2006 Apr; 25(18):2666-73. PubMed ID: 16314833
[TBL] [Abstract][Full Text] [Related]
38. DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis.
Nakagawa T; Kanai Y; Ushijima S; Kitamura T; Kakizoe T; Hirohashi S
J Urol; 2005 May; 173(5):1767-71. PubMed ID: 15821584
[TBL] [Abstract][Full Text] [Related]
39. Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis.
Roman-Gomez J; Jimenez-Velasco A; Agirre X; Prosper F; Heiniger A; Torres A
J Clin Oncol; 2005 Oct; 23(28):7043-9. PubMed ID: 16192589
[TBL] [Abstract][Full Text] [Related]
40. Quantitative analysis of promoter hypermethylation in multiple genes in osteosarcoma.
Hou P; Ji M; Yang B; Chen Z; Qiu J; Shi X; Lu Z
Cancer; 2006 Apr; 106(7):1602-9. PubMed ID: 16502411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
